124 related articles for article (PubMed ID: 12240935)
1. Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study.
Jung T; Kamm W; Breitenbach A; Klebe G; Kissel T
Pharm Res; 2002 Aug; 19(8):1105-13. PubMed ID: 12240935
[TBL] [Abstract][Full Text] [Related]
2. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T
Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276
[TBL] [Abstract][Full Text] [Related]
3. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres.
Jung T; Breitenbach A; Kissel T
J Control Release; 2000 Jul; 67(2-3):157-69. PubMed ID: 10825550
[TBL] [Abstract][Full Text] [Related]
4. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
5. The role of branched polyesters and their modifications in the development of modern drug delivery vehicles.
Dailey LA; Wittmar M; Kissel T
J Control Release; 2005 Jan; 101(1-3):137-49. PubMed ID: 15588900
[TBL] [Abstract][Full Text] [Related]
6. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
7. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
Gupta RK; Chang AC; Griffin P; Rivera R; Siber GR
Vaccine; 1996 Oct; 14(15):1412-6. PubMed ID: 8994315
[TBL] [Abstract][Full Text] [Related]
8. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin-loaded surface modified-PLGA nanoparticles confer sustained inhibitory effect against retinoblastoma cell in vitro.
Zhuang H; Xu YN; Zheng HH; Huan YR; Zheng NX; Lin L; Zhang WZ; Xu W
Arq Bras Oftalmol; 2022; 85(5):450-458. PubMed ID: 35170632
[TBL] [Abstract][Full Text] [Related]
10. Correlation between in vitro release and in vivo immune response from biodegradable polymer particles entrapping tetanus toxoid.
Raghuvanshi RS; Singh O; Panda AK
Drug Deliv; 2002; 9(2):113-20. PubMed ID: 12055039
[TBL] [Abstract][Full Text] [Related]
11. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
[TBL] [Abstract][Full Text] [Related]
12. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
13. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein.
Cai C; Bakowsky U; Rytting E; Schaper AK; Kissel T
Eur J Pharm Biopharm; 2008 May; 69(1):31-42. PubMed ID: 18023160
[TBL] [Abstract][Full Text] [Related]
14. Technological considerations related to the up-scaling of protein microencapsulation by spray-drying.
Johansen P; Merkle HP; Gander B
Eur J Pharm Biopharm; 2000 Nov; 50(3):413-7. PubMed ID: 11072199
[TBL] [Abstract][Full Text] [Related]
15. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
16. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.
Unger F; Wittmar M; Morell F; Kissel T
Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641
[TBL] [Abstract][Full Text] [Related]
17. New strategies for the microencapsulation of tetanus vaccine.
Schwendeman SP; Tobío M; Joworowicz M; Alonso MJ; Langer R
J Microencapsul; 1998; 15(3):299-318. PubMed ID: 9608394
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles.
Raghuvanshi RS; Singh O; Panda AK
Drug Deliv; 2001; 8(2):99-106. PubMed ID: 11400869
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Stabilized Gold-Folate-Poly(lactide-co-glycolide) Nanoplexes Facilitate Efficient Gene Delivery in Hepatic and Breast Cancer Cells.
Akinyelu J; Singh M
J Nanosci Nanotechnol; 2018 Jul; 18(7):4478-4486. PubMed ID: 29442622
[TBL] [Abstract][Full Text] [Related]
20. Poly-lactide-co-glycolide microparticle sizes: a rational factorial design and surface response analysis.
Namur JA; Cabral-Albuquerque EC; Quintilio W; Santana MH; Politi MJ; de Araujo PS; Lopes AC; da Costa MH
J Nanosci Nanotechnol; 2006 Aug; 6(8):2403-7. PubMed ID: 17037847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]